KOHJIN Life Sciences Co., Ltd. – Trademark Portfolio
Entity Type: 03
KOHJIN Life Sciences Co., Ltd. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 6 Nice Classification classes. Currently, 0 trademarks are registered and 1 is pending. The owner is based in Chiyoda-ku, Tokyo.
1-3, Yurakucho 1-Chome
Chiyoda-ku, Tokyo 1000006 , JP
Showing of trademarks Trademarks
Trademark Classifications
KOHJIN Life Sciences Co., Ltd.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does KOHJIN Life Sciences Co., Ltd. have?
KOHJIN Life Sciences Co., Ltd. has 10 U.S. trademarks filed with the USPTO. Of these, 1 pending, 1 cancelled.
What trademark classes does KOHJIN Life Sciences Co., Ltd. file in?
KOHJIN Life Sciences Co., Ltd. files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 1 (Chemicals), Class 4 (Lubricants & Fuels), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is KOHJIN Life Sciences Co., Ltd.'s trademark registration success rate?
KOHJIN Life Sciences Co., Ltd. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.